Zevra Therapeutics Short Position Overview
Recent data for Zevra Therapeutics (NASDAQ: ZVRA) indicates a current short interest level of 5.7 million shares. As of the latest reporting period, the stock maintains a days-to-cover ratio of 6.3, suggesting a moderate level of liquidity for short sellers to exit their positions. The borrow fee remains low at 0.3%, reflecting ample availability in the securities lending market for this pharmaceutical name.
Market Context
While short interest has fluctuated over the past two years, the company has seen a significant increase in shares outstanding, rising by approximately 37% during that period. Investors should monitor these levels as the company continues its clinical and commercial development phases. The current borrow cost indicates that there is currently no significant pressure or scarcity in the lending market for ZVRA shares.
Signal data sourced from CurvedTrading. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.